Get started
Author

Victoria E. Anderson

Observed names: Victoria E Anderson, Victoria Elizabeth Anderson
Observed institutions: Institute of Cancer Research, University of Michigan, Cancer Research UK, Adaptimmune (United Kingdom), Wellcome Centre for Cell Biology, University of Edinburgh
ORCID: 0000-0001-5468-7029
Observed ORCID: 0000-0001-5468-7029
OpenAlex ID: A5009496778
CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
2011 · Victoria E. Anderson, Michael I. Walton, et al. · Cancer Research · 114
PDF
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
2019 · Joseph P Sanderson, Darragh J Crowley, et al. · OncoImmunology · 101
Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer
2018 · Roslin Y. Docta, Tiago Ferronha, et al. · Hepatology · 58
PDF
Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
2009 · Stephen Hilton, Sebastien Naud, et al. · Bioorganic & Medicinal Chemistry · 57
Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2
2010 · John J. Caldwell, Emma J. Welsh, et al. · Journal of Medicinal Chemistry · 50
Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis
2008 · YN. Nguyen, Bryan A. McGuffie, et al. · Virology · 47
PDF
Novelsfi1Alleles Uncover Additional Functions for Sfi1p in Bipolar Spindle Assembly and Function
2007 · Victoria E. Anderson, John Prudden, et al. · Molecular Biology of the Cell · 33
Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8α
2023 · Victoria E. Anderson, Sara S. Brilha, et al. · Journal of Immunotherapy · 19
Abstract 2313: Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8α homodimer
2019 · Victoria E. Anderson, Anika M. Weber, et al. · Cancer Research · 4
Corrigendum to “Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2” [Bioorg. Med. Chem. 18 (2010) 707]
2010 · Stephen Hilton, Sebastien Naud, et al. · Bioorganic & Medicinal Chemistry · 4
Selection, engineering, and in vivo testing of a human leukocyte antigen–independent T-cell receptor recognizing human mesothelin
2024 · Martyn J. Hiscox, Alexandra Wasmuth, et al. · PLoS ONE · 1
Abstract 2313: Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8α homodimer
2019 · Victoria E. Anderson, Anika M. Weber, et al. · Immunology · 1
Supplementary Tables 1-3 from CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
2023 · Victoria E. Anderson, Michael I. Walton, et al.
Supplementary Figures 1-4 from CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
2023 · Victoria E. Anderson, Michael I. Walton, et al.
PDF
Supplementary Materials from CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
2023 · Victoria E. Anderson, Michael I. Walton, et al.
Data from CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
2023 · Victoria E. Anderson, Michael I. Walton, et al.
Abstract 3503: CCT241533 is a novel, potent and selective inhibitor of CHK2 and potentiates the cellular effects of PARP inhibitors
2010 · Victoria E. Anderson, Paul D. Eve, et al. · Cancer Research
Sfi1p has multiple roles in the spindle pole body cycle
2006 · Victoria E. Anderson · ERA
Works count: 18
Citation count: 489
H-index: 8
I10-index: 8
Year
Topic
Type